免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA PMA

Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring

PMA编号:P200041 · 2026-07-31

决定日期2026-07-31
PMA 编号P200041
产品代码NWX
设备分类第3类
医疗专科U
咨询委员会CV 请注意,由于原文未提供具体内容,以下是一个示例翻译: --- 产品名称:[产品名称] 公司名称:[公司名称] FDA批准号:[FDA批准号] 510(k)申请号:[510(k)申请号] PMA申请号:[PMA申请号] 临床试验注册号:[NCT] PubMed ID:[PMID] 产品标识符:[标识符] 产品URL:[URL] --- 请将上述示例中的[产品名称]、[公司名称]、[FDA批准号]等占位符替换为实际内容。

器械摘要

Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring is the device name listed in this FDA 510(k) record. The listed applicant is OrbusNeich Medical (Shenzhen) Co., Ltd.. It received FDA 510(k) clearance on 2026-07-31. The device is classified under product code NWX. It was reviewed by the CV advisory panel.

常见问题

What is the Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring?

Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring is a medical device that received FDA 510(k) clearance on 2026-07-31. The listed applicant is OrbusNeich Medical (Shenzhen) Co., Ltd..

When did Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring receive FDA 510(k) clearance?

The clearance date for Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring can be found in the official FDA records.

谁是Catheter,经皮冠状动脉腔内成形术(PTCA),切割/打分产品的列名申请人?

FDA 510(k)记录将奥布斯尼奇医疗(深圳)有限公司列为申请人。这本身并不能确立该设备制造商的身份。

FDA导管、经皮腔内冠状动脉成形术(PTCA)、切割/打分产品的代码是什么?

FDA产品代码为Catheter,经皮腔内冠状动脉成形术(PTCA),切割/打分的是NWX。

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑